EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.21p on 28-01-2026 at 19:15:14 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.22p |
| Sell | 0.20p |
| Last Trade: | Sell 30,000.00 at 0.202p |
| Day's Volume: | 182,657 |
| Last Close: | 0.21p |
| Open: | 0.21p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.21p - 0.21p |
| 52wk Range: | 0.18p - 1.22p |
| Market Capitalisation: | £4.51m |
| VWAP: | 0.207761p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 30,000 | 0.202p | Ordinary |
16:22:28 - 28-Jan-26 |
| Buy* | 40,000 | 0.2135p | Ordinary |
08:31:04 - 28-Jan-26 |
| Sell* | 120,245 | 0.20p | Ordinary |
16:28:24 - 27-Jan-26 |
| Sell* | 154,000 | 0.20p | Ordinary |
15:49:07 - 27-Jan-26 |
| Buy* | 18,023 | 0.2135p | Ordinary |
14:47:38 - 27-Jan-26 |
| Sell* | 84,848 | 0.202p | Ordinary |
13:27:26 - 27-Jan-26 |
| Sell* | 91,954 | 0.202p | Ordinary |
13:08:06 - 27-Jan-26 |
| Buy* | 928,995 | 0.214p | Ordinary |
12:42:49 - 27-Jan-26 |
| Buy* | 699,953 | 0.2143p | Ordinary |
11:22:07 - 27-Jan-26 |
| Buy* | 40,909 | 0.22p | Ordinary |
10:41:06 - 27-Jan-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am | RNS-R | Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am | RNS | Half-year Financial Report |
| 26th Nov 2025 7:00 am | RNS-R | Marking Addiction Awareness Week |
| 24th Nov 2025 7:00 am | RNS | Notice of Results |
| 3rd Nov 2025 7:00 am | RNS | Ox-1 Programme Achieves Manufacturing Milestone |
| 16th Oct 2025 4:45 pm | RNS | Holding(s) in Company |
| 16th Oct 2025 4:45 pm | RNS | Director/PDMR Shareholding |
| 10th Oct 2025 7:00 am | RNS-R | World Mental Health Day & Q4 Conference Schedule |